Characterization of actionable genetic alterations to guide targeted therapy for metastatic urothelial carcinoma.
Year: 2019
Type: conference-abstract
Source: Journal of Clinical Oncology
Institution: Memorial Sloan Kettering Cancer Center
Language: English
Subfield: Surgery
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2920818575
